Latest news
Loading news…
Amylin Pharmaceuticals is a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs.
Amylin Pharmaceuticals was acquired by Bristol-Myers Squibb in 2012 for $5B.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Investments
2
1 exits
Monthly Visits
Available in Pro Contacts
198
Patents
34
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 6
- Active products
- 6
- Patents granted
- 34
- Trademarks
- 0
- Top patent class
- Medical Or Veterinary Science; Hygiene
Investor Activity
- Investments
- 2
- Lead investments
- 1
- Portfolio orgs
- 2
- Exits
- 1
Company Info
- Org types
- company, investor
- HQ
- San Diego, California, United States
Signals & Scores
- Trend (7d)
- 3.4
- Trend (30d)
- 6.4
- Trend (90d)
- 5.6
Investments by Amylin Pharmaceuticals
Loading columns…
0 of 0Show
Page 1 / 1
198
professional contacts at Amylin Pharmaceuticals
Contact execs at Amylin Pharmaceuticals →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Amylin Pharmaceuticals
Loading news…
FAQs about Amylin Pharmaceuticals
People who checked this page also checked these
Browse the full Acquirezy directory.